$OTLC·4

OXIGENE INC · Jan 22, 11:47 AM ET

OXIGENE INC 4

4 · OXIGENE INC · Filed Jan 22, 2009

Insider Transaction Report

Form 4
Period: 2009-01-20
CHAPLIN DAVID
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2009-01-20+120,000120,000 total
    Exercise: $0.65From: 2010-01-20Exp: 2019-01-20Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The option vests in four equal annual installments starting one year from the date of grant.

Documents

1 file
  • 4
    rrd230479.xmlPrimary

    FORM 4